{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:39:03Z","timestamp":1790116743574,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Youth Fund of National Natural Science Foundation of China grant","award":["82001973"],"award-info":[{"award-number":["82001973"]}]},{"name":"the Youth Project Co-established by Henan Province and the Ministry grant","award":["SBGJ2020003017"],"award-info":[{"award-number":["SBGJ2020003017"]}]},{"name":"the Health Science and Technology Innovation Excellent Youth Training Project in Henan province grant","award":["YXKC2020057"],"award-info":[{"award-number":["YXKC2020057"]}]},{"name":"National Key R&D Program of China grant","award":["2017YFA0105000"],"award-info":[{"award-number":["2017YFA0105000"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China grants","doi-asserted-by":"crossref","award":["U1904207"],"award-info":[{"award-number":["U1904207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93369-8","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:54:21Z","timestamp":1744217661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genome editing in spinocerebellar ataxia type 3 cells improves Golgi apparatus structure"],"prefix":"10.1038","volume":"15","author":[{"given":"Yanlin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhe","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"93369_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/s1474-4422(21)00462-2","volume":"21","author":"K Iba\u00f1ez","year":"2022","unstructured":"Iba\u00f1ez, K. et al. Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study. Lancet Neurol. 21, 234\u2013245. https:\/\/doi.org\/10.1016\/s1474-4422(21)00462-2 (2022).","journal-title":"Lancet Neurol."},{"key":"93369_CR2","doi-asserted-by":"publisher","first-page":"eabm5386","DOI":"10.1126\/sciadv.abm5386","volume":"8","author":"I Stevanovski","year":"2022","unstructured":"Stevanovski, I. et al. Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing. Sci. Adv. 8, eabm5386. https:\/\/doi.org\/10.1126\/sciadv.abm5386 (2022).","journal-title":"Sci. Adv."},{"key":"93369_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/s1474-4422(22)00121-1","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi, S. J. et al. Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities. Lancet Neurol. 21, 645\u2013658. https:\/\/doi.org\/10.1016\/s1474-4422(22)00121-1 (2022).","journal-title":"Lancet Neurol."},{"key":"93369_CR4","doi-asserted-by":"publisher","first-page":"104635","DOI":"10.1016\/j.nbd.2019.104635","volume":"134","author":"HS McLoughlin","year":"2020","unstructured":"McLoughlin, H. S., Moore, L. R. & Paulson, H. L. Pathogenesis of SCA3 and implications for other polyglutamine diseases. Neurobiol. Dis. 134, 104635. https:\/\/doi.org\/10.1016\/j.nbd.2019.104635 (2020).","journal-title":"Neurobiol. Dis."},{"key":"93369_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s13311-019-00798-1","volume":"16","author":"JD Da Silva","year":"2019","unstructured":"Da Silva, J. D., Teixeira-Castro, A. & Maciel, P. From pathogenesis to novel therapeutics for spinocerebellar Ataxia type 3: evading potholes on the way to translation. Neurotherapeutics 16, 1009\u20131031. https:\/\/doi.org\/10.1007\/s13311-019-00798-1 (2019).","journal-title":"Neurotherapeutics"},{"key":"93369_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pneurobio.2015.06.004","volume":"132","author":"X Li","year":"2015","unstructured":"Li, X., Liu, H., Fischhaber, P. L. & Tang, T. S. Toward therapeutic targets for SCA3: insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance. Prog Neurobiol. 132, 34\u201358. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.06.004 (2015).","journal-title":"Prog Neurobiol."},{"key":"93369_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/hmg\/ddi472","volume":"15","author":"A Haacke","year":"2006","unstructured":"Haacke, A. et al. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3. Hum. Mol. Genet. 15, 555\u2013568. https:\/\/doi.org\/10.1093\/hmg\/ddi472 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"93369_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/hum.2018.157","volume":"30","author":"C N\u00f3brega","year":"2019","unstructured":"N\u00f3brega, C., Cod\u00easso, J. M.  Mendon\u00e7a, L. & Pereira de Almeida, L. RNA interference therapy for Machado-Joseph disease: Long-Term safety profile of lentiviral vectors encoding short hairpin RNAs targeting mutant Ataxin-3. Hum. Gene Ther. 30, 841\u2013854. https:\/\/doi.org\/10.1089\/hum.2018.157 (2019).","journal-title":"Hum. Gene Ther."},{"key":"93369_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.omtn.2017.06.019","volume":"8","author":"LJA Toonen","year":"2017","unstructured":"Toonen, L. J. A., Rigo, F., van Attikum, H. & van Roon-Mom, W. M. C. Antisense Oligonucleotide-Mediated removal of the polyglutamine repeat in spinocerebellar Ataxia type 3 mice. Mol. Ther. Nucleic Acids. 8, 232\u2013242. https:\/\/doi.org\/10.1016\/j.omtn.2017.06.019 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"93369_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.cell.2010.10.029","volume":"143","author":"T Matsuki","year":"2010","unstructured":"Matsuki, T. et al. Reelin and stk25 have opposing roles in neuronal polarization and dendritic golgi deployment. Cell 143, 826\u2013836. https:\/\/doi.org\/10.1016\/j.cell.2010.10.029 (2010).","journal-title":"Cell"},{"issue":"Suppl 3","key":"93369_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/jad-132660","volume":"42","author":"SJ Baloyannis","year":"2014","unstructured":"Baloyannis, S. J. Golgi apparatus and protein trafficking in Alzheimer\u2019s disease. J. Alzheimer\u2019s Disease: JAD. 42 (Suppl 3), 153\u2013162. https:\/\/doi.org\/10.3233\/jad-132660 (2014).","journal-title":"J. Alzheimer\u2019s Disease: JAD"},{"key":"93369_CR12","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1080\/15548627.2018.1491214","volume":"14","author":"X Zhang","year":"2018","unstructured":"Zhang, X. & Wang, Y. The golgi stacking protein GORASP2\/GRASP55 serves as an energy sensor to promote autophagosome maturation under glucose starvation. Autophagy 14, 1649\u20131651. https:\/\/doi.org\/10.1080\/15548627.2018.1491214 (2018).","journal-title":"Autophagy"},{"key":"93369_CR13","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41380-022-01926-8","volume":"28","author":"K Crawford","year":"2023","unstructured":"Crawford, K. et al. Golgi apparatus, Endoplasmic reticulum and mitochondrial function implicated in Alzheimer\u2019s disease through polygenic risk and RNA sequencing. Mol. Psychiatry. 28, 1327\u20131336. https:\/\/doi.org\/10.1038\/s41380-022-01926-8 (2023).","journal-title":"Mol. Psychiatry"},{"key":"93369_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41380-018-0221-3","volume":"24","author":"AN Vagnozzi","year":"2019","unstructured":"Vagnozzi, A. N. & Pratic\u00f2, D. Endosomal sorting and trafficking, the retromer complex and neurodegeneration. Mol. Psychiatry. 24, 857\u2013868. https:\/\/doi.org\/10.1038\/s41380-018-0221-3 (2019).","journal-title":"Mol. Psychiatry"},{"key":"93369_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s12272-022-01408-z","volume":"45","author":"W Choi","year":"2022","unstructured":"Choi, W., Kang, S. & Kim, J. New insights into the role of the golgi apparatus in the pathogenesis and therapeutics of human diseases. Arch. Pharm. Res. 45, 671\u2013692. https:\/\/doi.org\/10.1007\/s12272-022-01408-z (2022).","journal-title":"Arch. Pharm. Res."},{"key":"93369_CR16","doi-asserted-by":"publisher","first-page":"116646","DOI":"10.1016\/j.biopha.2024.116646","volume":"175","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. Early signs of neurodegenerative diseases: possible mechanisms and targets for golgi stress. Biomed. Pharmacother. 175, 116646. https:\/\/doi.org\/10.1016\/j.biopha.2024.116646 (2024).","journal-title":"Biomed. Pharmacother"},{"key":"93369_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-016-0111-6","volume":"11","author":"S Bellouze","year":"2016","unstructured":"Bellouze, S. et al. Stathmin 1\/2-triggered microtubule loss mediates golgi fragmentation in mutant SOD1 motor neurons. Mol. Neurodegener. 11, 43. https:\/\/doi.org\/10.1186\/s13024-016-0111-6 (2016).","journal-title":"Mol. Neurodegener"},{"key":"93369_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1073\/pnas.1608576114","volume":"114","author":"C Liu","year":"2017","unstructured":"Liu, C. et al. Loss of the golgin GM130 causes golgi disruption, purkinje neuron loss, and ataxia in mice. Proc. Natl. Acad. Sci. U.S.A. 114, 346\u2013351. https:\/\/doi.org\/10.1073\/pnas.1608576114 (2017).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"93369_CR19","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3760\/cma.j.cn113694-20211223-00915","volume":"55","author":"WZ Wang Yanlin","year":"2022","unstructured":"Wang Yanlin, W. Z., Wang Zhilei, S., Huifang, Z., Qi, C. & Na, X. Morphological alterations study in the golgi apparatus of skin fibroblasts in spinocerebellar ataxia type 3 patients. Chin. J. Neurol. 55, 993\u20131001. https:\/\/doi.org\/10.3760\/cma.j.cn113694-20211223-00915 (2022).","journal-title":"Chin. J. Neurol."},{"key":"93369_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ana.20501","volume":"57","author":"OY Bang","year":"2005","unstructured":"Bang, O. Y., Lee, J. S., Lee, P. H. & Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57, 874\u2013882. https:\/\/doi.org\/10.1002\/ana.20501 (2005).","journal-title":"Ann. Neurol."},{"key":"93369_CR21","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1016\/s0140-6736(22)00662-6","volume":"399","author":"M Kamdar","year":"2022","unstructured":"Kamdar, M. et al. Lisocabtagene Maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial. Lancet (London England). 399, 2294\u20132308. https:\/\/doi.org\/10.1016\/s0140-6736(22)00662-6 (2022).","journal-title":"Lancet (London England)"},{"key":"93369_CR22","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","volume":"376","author":"M Mandai","year":"2017","unstructured":"Mandai, M. et al. Autologous induced stem-cell-derived retinal cells for macular degeneration. N. Engl. J. Med. 376, 1038\u20131046. https:\/\/doi.org\/10.1056\/NEJMoa1608368 (2017).","journal-title":"N. Engl. J. Med."},{"key":"93369_CR23","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","volume":"382","author":"JS Schweitzer","year":"2020","unstructured":"Schweitzer, J. S. et al. Personalized iPSC-derived dopamine progenitor cells for Parkinson\u2019s disease. N Engl. J. Med. 382, 1926\u20131932. https:\/\/doi.org\/10.1056\/NEJMoa1915872 (2020).","journal-title":"N Engl. J. Med."},{"key":"93369_CR24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1172\/JCI130767","volume":"130","author":"B Song","year":"2020","unstructured":"Song, B. et al. Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson\u2019s disease models. J. Clin. Invest. 130, 904\u2013920. https:\/\/doi.org\/10.1172\/JCI130767 (2020).","journal-title":"J. Clin. Invest."},{"key":"93369_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","volume":"20","author":"RG Rowe","year":"2019","unstructured":"Rowe, R. G. & Daley, G. Q. Induced pluripotent stem cells in disease modelling and drug discovery. Nat. Rev. Genet. 20, 377\u2013388. https:\/\/doi.org\/10.1038\/s41576-019-0100-z (2019).","journal-title":"Nat. Rev. Genet."},{"key":"93369_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-biochem-060815-014607","volume":"85","author":"H Wang","year":"2016","unstructured":"Wang, H., La Russa, M. & Qi, L. S. CRISPR\/Cas9 in genome editing and beyond. Annu. Rev. Biochem. 85, 227\u2013264. https:\/\/doi.org\/10.1146\/annurev-biochem-060815-014607 (2016).","journal-title":"Annu. Rev. Biochem."},{"key":"93369_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-022-01518-8","volume":"21","author":"SW Wang","year":"2022","unstructured":"Wang, S. W. et al. Current applications and future perspective of CRISPR\/Cas9 gene editing in cancer. Mol. Cancer. 21, 57. https:\/\/doi.org\/10.1186\/s12943-022-01518-8 (2022).","journal-title":"Mol. Cancer"},{"key":"93369_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/7651_2020_337","volume":"2454","author":"P Petazzi","year":"2022","unstructured":"Petazzi, P., Men\u00e9ndez, P. & Sevilla, A. CRISPR\/Cas9-mediated gene knockout and knockin human iPSCs. Methods Mol. Biology (Clifton N J). 2454, 559\u2013574. https:\/\/doi.org\/10.1007\/7651_2020_337 (2022).","journal-title":"Methods Mol. Biology (Clifton N J)"},{"key":"93369_CR29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41398-021-01605-2","volume":"11","author":"L He","year":"2021","unstructured":"He, L. et al. CRISPR\/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells. Transl Psychiatry. 11, 479. https:\/\/doi.org\/10.1038\/s41398-021-01605-2 (2021).","journal-title":"Transl Psychiatry"},{"key":"93369_CR30","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1089\/scd.2017.0209","volume":"27","author":"S Ouyang","year":"2018","unstructured":"Ouyang, S. et al. CRISPR\/Cas9-Targeted deletion of polyglutamine in spinocerebellar Ataxia type 3-Derived induced pluripotent stem cells. Stem Cells Dev. 27, 756\u2013770. https:\/\/doi.org\/10.1089\/scd.2017.0209 (2018).","journal-title":"Stem Cells Dev."},{"key":"93369_CR31","doi-asserted-by":"publisher","unstructured":"Binda, C. S., Klaver, B., Berkhout, B. & Das, A. T. CRISPR-Cas9 dual-gRNA attack causes mutation, excision and inversion of the HIV-1 Proviral DNA. Viruses 12 (2020). https:\/\/doi.org\/10.3390\/v12030330","DOI":"10.3390\/v12030330"},{"key":"93369_CR32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.omtm.2020.10.007","volume":"19","author":"S L\u00f3pez-Manzaneda","year":"2020","unstructured":"L\u00f3pez-Manzaneda, S. et al. In vitro and in vivo genetic disease modeling via NHEJ-precise deletions using CRISPR-Cas9. Mol. Therapy Methods Clin. Dev. 19, 426\u2013437. https:\/\/doi.org\/10.1016\/j.omtm.2020.10.007 (2020).","journal-title":"Mol. Therapy Methods Clin. Dev."},{"key":"93369_CR33","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1016\/j.ymthe.2018.09.003","volume":"26","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Therapeutic genome editing for myotonic dystrophy type 1 using CRISPR\/Cas9. Mol. Ther. 26, 2617\u20132630. https:\/\/doi.org\/10.1016\/j.ymthe.2018.09.003 (2018).","journal-title":"Mol. Ther."},{"key":"93369_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40478-022-01329-4","volume":"10","author":"CO Miranda","year":"2022","unstructured":"Miranda, C. O. et al. Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph disease. Acta Neuropathol. Commun. 10, 37. https:\/\/doi.org\/10.1186\/s40478-022-01329-4 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"93369_CR35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41419-022-05085-0","volume":"13","author":"X Han","year":"2022","unstructured":"Han, X. et al. Transcription factor EB-mediated mesenchymal stem cell therapy induces autophagy and alleviates spinocerebellar ataxia type 3 defects in neuronal cells model. Cell. Death Dis. 13, 622. https:\/\/doi.org\/10.1038\/s41419-022-05085-0 (2022).","journal-title":"Cell. Death Dis."},{"key":"93369_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1365-2990.2011.01220.x","volume":"38","author":"K Seidel","year":"2012","unstructured":"Seidel, K. et al. Cellular protein quality control and the evolution of aggregates in spinocerebellar ataxia type 3 (SCA3). Neuropathol. Appl. Neurobiol. 38, 548\u2013558. https:\/\/doi.org\/10.1111\/j.1365-2990.2011.01220.x (2012).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"93369_CR37","doi-asserted-by":"publisher","first-page":"28576","DOI":"10.1074\/jbc.M111.299990","volume":"287","author":"H Wang","year":"2012","unstructured":"Wang, H., Ying, Z. & Wang, G. Ataxin-3 regulates aggresome formation of copper-zinc superoxide dismutase (SOD1) by editing K63-linked Polyubiquitin chains. J. Biol. Chem. 287, 28576\u201328585. https:\/\/doi.org\/10.1074\/jbc.M111.299990 (2012).","journal-title":"J. Biol. Chem."},{"key":"93369_CR38","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ijbiomac.2022.07.133","volume":"218","author":"ZS Chen","year":"2022","unstructured":"Chen, Z. S. et al. Lignin-carbohydrate complexes suppress SCA3 neurodegeneration via upregulating proteasomal activities. Int. J. Biol. Macromol. 218, 690\u2013705. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.07.133 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"93369_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1142\/s0192415x19500046","volume":"47","author":"IC Chen","year":"2019","unstructured":"Chen, I. C. et al. Targeting ubiquitin proteasome pathway with traditional Chinese medicine for treatment of spinocerebellar Ataxia type 3. Am. J. Chin. Med. 47, 63\u201395. https:\/\/doi.org\/10.1142\/s0192415x19500046 (2019).","journal-title":"Am. J. Chin. Med."},{"key":"93369_CR40","doi-asserted-by":"publisher","first-page":"e23429","DOI":"10.1096\/fj.202300963RR","volume":"38","author":"M Watchon","year":"2024","unstructured":"Watchon, M. et al. Treatment with sodium butyrate induces autophagy resulting in therapeutic benefits for spinocerebellar ataxia type 3. Faseb J. 38, e23429. https:\/\/doi.org\/10.1096\/fj.202300963RR (2024).","journal-title":"Faseb J."},{"key":"93369_CR41","doi-asserted-by":"publisher","unstructured":"Lee, J. H. et al. n-Butylidenephthalide modulates autophagy to ameliorate neuropathological progress of spinocerebellar Ataxia type 3 through mTOR pathway. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22126339 (2021).","DOI":"10.3390\/ijms22126339"},{"key":"93369_CR42","doi-asserted-by":"publisher","first-page":"e12763","DOI":"10.1111\/nan.12763","volume":"48","author":"A Vasconcelos-Ferreira","year":"2022","unstructured":"Vasconcelos-Ferreira, A. et al. The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease. Neuropathol. Appl. Neurobiol. 48, e12763. https:\/\/doi.org\/10.1111\/nan.12763 (2022).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"93369_CR43","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s12015-019-09903-5","volume":"15","author":"P Shende","year":"2019","unstructured":"Shende, P., Bhandarkar, S. & Prabhakar, B. Heat shock proteins and their protective roles in stem cell biology. Stem Cell. Rev. Rep. 15, 637\u2013651. https:\/\/doi.org\/10.1007\/s12015-019-09903-5 (2019).","journal-title":"Stem Cell. Rev. Rep."},{"key":"93369_CR44","doi-asserted-by":"publisher","unstructured":"Johnson, S. L., Ranxhi, B., Libohova, K., Tsou, W. L. & Todi, S. V. Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation. Elife. https:\/\/doi.org\/10.7554\/eLife.60742 (2020).","DOI":"10.7554\/eLife.60742"},{"key":"93369_CR45","doi-asserted-by":"publisher","first-page":"10424","DOI":"10.1073\/pnas.0914773107","volume":"107","author":"AL Robertson","year":"2010","unstructured":"Robertson, A. L. et al. Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation. Proc. Natl. Acad. Sci. U S A. 107, 10424\u201310429. https:\/\/doi.org\/10.1073\/pnas.0914773107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"93369_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae304","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Treatment of neurologic pathology and inflammation in Machado-Joseph disease through in vivo self-assembled SiRNA. Brain https:\/\/doi.org\/10.1093\/brain\/awae304 (2024).","journal-title":"Brain"},{"key":"93369_CR47","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.ymthe.2023.04.001","volume":"31","author":"D Rufino-Ramos","year":"2023","unstructured":"Rufino-Ramos, D. et al. Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease\/spinocerebellar ataxia type 3. Mol. Ther. 31, 1275\u20131292. https:\/\/doi.org\/10.1016\/j.ymthe.2023.04.001 (2023).","journal-title":"Mol. Ther."},{"key":"93369_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.omtn.2021.11.015","volume":"27","author":"S Hauser","year":"2022","unstructured":"Hauser, S. et al. Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons. Mol. Ther. Nucleic Acids. 27, 99\u2013108. https:\/\/doi.org\/10.1016\/j.omtn.2021.11.015 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"93369_CR49","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ana.26713","volume":"94","author":"HS McLoughlin","year":"2023","unstructured":"McLoughlin, H. S. et al. Antisense oligonucleotide silencing reverses abnormal neurochemistry in spinocerebellar Ataxia 3 mice. Ann. Neurol. 94, 658\u2013671. https:\/\/doi.org\/10.1002\/ana.26713 (2023).","journal-title":"Ann. Neurol."},{"key":"93369_CR50","doi-asserted-by":"publisher","first-page":"102119","DOI":"10.1016\/j.ceb.2022.102119","volume":"78","author":"S Kemal","year":"2022","unstructured":"Kemal, S., Richardson, H. S., Dyne, E. D. & Fu, M. M. ER and golgi trafficking in axons, dendrites, and glial processes. Curr. Opin. Cell Biol. 78, 102119. https:\/\/doi.org\/10.1016\/j.ceb.2022.102119 (2022).","journal-title":"Curr. Opin. Cell Biol."},{"key":"93369_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fnins.2015.00397","volume":"9","author":"D Jaarsma","year":"2015","unstructured":"Jaarsma, D. & Hoogenraad, C. C. Cytoplasmic dynein and its regulatory proteins in golgi pathology in nervous system disorders. Front. NeuroSci. 9, 397. https:\/\/doi.org\/10.3389\/fnins.2015.00397 (2015).","journal-title":"Front. NeuroSci."},{"key":"93369_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.04.005","volume":"168","author":"KC Sonntag","year":"2018","unstructured":"Sonntag, K. C. et al. Pluripotent stem cell-based therapy for Parkinson\u2019s disease: current status and future prospects. Prog Neurobiol. 168, 1\u201320. https:\/\/doi.org\/10.1016\/j.pneurobio.2018.04.005 (2018).","journal-title":"Prog Neurobiol."},{"key":"93369_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-981-15-4370-8_5","volume":"1266","author":"R Monk","year":"2020","unstructured":"Monk, R. & Connor, B. Cell replacement therapy for Huntington\u2019s disease. Adv. Exp. Med. Biol. 1266, 57\u201369. https:\/\/doi.org\/10.1007\/978-981-15-4370-8_5 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"93369_CR54","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/mds.26026","volume":"29","author":"A Rosser","year":"2014","unstructured":"Rosser, A. & Svendsen, C. N. Stem cells for cell replacement therapy: a therapeutic strategy for HD? Mov. Disorders: Official J. Mov. Disorder Soc. 29, 1446\u20131454. https:\/\/doi.org\/10.1002\/mds.26026 (2014).","journal-title":"Mov. Disorders: Official J. Mov. Disorder Soc."},{"key":"93369_CR55","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1755-5949.2011.00239.x","volume":"18","author":"Z Feng","year":"2012","unstructured":"Feng, Z. & Gao, F. Stem cell challenges in the treatment of neurodegenerative disease. CNS Neurosci. Ther. 18, 142\u2013148. https:\/\/doi.org\/10.1111\/j.1755-5949.2011.00239.x (2012).","journal-title":"CNS Neurosci. Ther."},{"key":"93369_CR56","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019 (2007).","journal-title":"Cell"},{"key":"93369_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-016-0106-3","volume":"11","author":"J Yang","year":"2016","unstructured":"Yang, J., Li, S., He, X. B., Cheng, C. & Le, W. Induced pluripotent stem cells in Alzheimer\u2019s disease: applications for disease modeling and cell-replacement therapy. Mol. Neurodegeneration. 11, 39. https:\/\/doi.org\/10.1186\/s13024-016-0106-3 (2016).","journal-title":"Mol. Neurodegeneration"},{"key":"93369_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.scr.2018.01.027","volume":"28","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Generation of induced pluripotent stem cell line (ZZUi004-A) from urine sample of a patient with spinocerebellar ataxia type 3. Stem Cell. Res. 28, 71\u201374. https:\/\/doi.org\/10.1016\/j.scr.2018.01.027 (2018).","journal-title":"Stem Cell. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93369-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T02:01:05Z","timestamp":1744596065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93369-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93369"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93369-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12106"}}